MAXCYTE, INC.MXCTEarnings & Financial Report
Nasdaq
MXCT Q3 2025 Key Financial Metrics
Revenue
$4.6M
Gross Profit
$5.2M
Operating Profit
$-14.1M
Net Profit
$-12.4M
Gross Margin
113.7%
Operating Margin
-307.4%
Net Margin
-269.7%
YoY Growth
-18.0%
EPS
$-0.12
Financial Flow
MAXCYTE, INC. Q3 2025 Financial Summary
MAXCYTE, INC. reported revenue of $4.6M for Q3 2025, with a net profit of $-12.4M (-269.7% margin). Cost of goods sold was $-630.0K, operating expenses totaled $19.4M.
Key Financial Metrics
| Total Revenue | $4.6M |
|---|---|
| Net Profit | $-12.4M |
| Gross Margin | 113.7% |
| Operating Margin | -307.4% |
| Report Period | Q3 2025 |
MAXCYTE, INC. Annual Revenue by Year
MAXCYTE, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $22.2M).
| Year | Annual Revenue |
|---|---|
| 2024 | $22.2M |
| 2023 | $19.5M |
| 2022 | $28.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8M | $5.6M | $5.0M | $5.6M | $6.1M | $5.7M | $5.8M | $4.6M |
| YoY Growth | -38.8% | 12.5% | -11.7% | 34.9% | 27.4% | 2.8% | 17.3% | -18.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $268.3M | $257.9M | $251.5M | $248.6M | $239.5M | $230.0M | $219.8M | $213.5M |
| Liabilities | $36.1M | $31.6M | $30.2M | $35.3M | $33.2M | $30.5M | $29.0M | $33.2M |
| Equity | $232.2M | $226.4M | $221.3M | $213.3M | $206.3M | $199.4M | $190.7M | $180.3M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $981700 | $-10.6M | $-4.8M | $-4.4M | $-7.8M | $-14.4M | $-9.9M | $-7.5M |